or
Bookmark and Share
Use of angelicin and of its structural analogues for the treatment of thalassemia
   
Document Number
US Patent 7572827
Issued Date
August 11, 2009
Link
Map
Abstract
The use of angelicin and its structural analogues for the preparation of a medicament for the therapeutic treatment of beta-thalassaemia is described. A structural analogue which is particularly preferred for this purpose is bergapten.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
2
Comments:
no comments yet
Published
August 11, 2009
Application Number
10/522,737
Filed
July 30, 2003
US Classification
514/453  
Int'l Classification
A61K   31/366   (20060101)  
Attorney/Law Firm
Priority Data
Jul 31, 2002 [IT] TO02A0684
USPTO Field of Search
Related Patents
Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us